ArticleJTO clinical and research reports2025
Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Limited-Stage SCLC.
Sheng-Han Tsai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJTO clinical and research reports2025
Sheng-Han Tsai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.